INOTEK PHARMACEUTICALS CORP 4
4 · INOTEK PHARMACEUTICALS CORP · Filed Mar 24, 2016
Insider Transaction Report
Form 4
RITTER DALE
Vice President, Finance
Transactions
- Award
Stock Options (Right to Buy)
2016-03-22+40,000→ 40,000 totalExercise: $7.56Exp: 2026-03-21→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan (the "Plan"). 25% of the options granted shall vest on the one year anniversary of January 1, 2016 and 1/36th of the remaining option grant shall vest on each monthly anniversary thereafter, subject to continued service through such dates.
- [F2]As previously reported on June 26, 2015, the Reporting Person was granted a stock option award under the Plan. The total beneficially owned derivative securities following the grant inadvertently included securities of a separate class, and accordingly such previously inadvertently reported shares are now properly excluded. In addition, the Price of Derivative Security reported on the June 26, 2015 Form 4 was inadvertently reported as $5.03 when it should have properly been recorded as $0.